First-line pembrolizumab plus chemotherapy for patients with advanced squamous NSCLC: 3-year follow-up from KEYNOTE-407

Robinson, A. G.Vicente, D.Tafreshi, A.Parra, H. SotoMazieres, J.Cicin, I.Medgyasszay, B.2024-06-122024-06-1220211556-08641556-1380https://hdl.handle.net/20.500.14551/26789[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keywords]First-line pembrolizumab plus chemotherapy for patients with advanced squamous NSCLC: 3-year follow-up from KEYNOTE-407Conference Object164S748S749Q1WOS:000634855900098